Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127201811 | 12720181 | 1 | I | 20160824 | 20160907 | 20160907 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-123105 | RANBAXY | KAUFMAN KR, NEWMAN NB, DAWOOD A.. CAPGRAS DELUSION WITH VIOLENT BEHAVIOR IN ALZHEIMER DEMENTIA: CASE ANALYSIS WITH LITERATURE REVIEW. ANNALS OF CLINICAL PSYCHIATRY. 2014;26 (3):187-191 | 75.00 | YR | M | Y | 0.00000 | 20160907 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127201811 | 12720181 | 1 | PS | Amitriptyline | AMITRIPTYLINE | 1 | Unknown | 50 MG, BID | Y | U | UNK | 40816 | 50 | MG | Q12H | ||||
| 127201811 | 12720181 | 2 | SS | Amitriptyline | AMITRIPTYLINE | 1 | Unknown | 30 MG AT NIGHTLY AT BEDTIME | Y | U | UNK | 40816 | 30 | MG | |||||
| 127201811 | 12720181 | 3 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | 100 MG, BID | Y | U | UNK | 0 | 100 | MG | Q12H | ||||
| 127201811 | 12720181 | 4 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | 100 MG, QD NIGHTLY AT BEDTIME | Y | U | UNK | 0 | 100 | MG | |||||
| 127201811 | 12720181 | 5 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 100 MG, QD AT BEDTIME | UNK | 0 | 100 | MG | |||||||
| 127201811 | 12720181 | 6 | SS | OLANZAPINE. | OLANZAPINE | 1 | Unknown | 15 MG NIGHTLY AT BEDTIME | Y | U | UNK | 0 | 15 | MG | |||||
| 127201811 | 12720181 | 7 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 50 MG ONCE IN THE MORNING | UNK | 0 | 50 | MG | |||||||
| 127201811 | 12720181 | 8 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 50 MG NIGHTLY AT BED TIME | UNK | 0 | 50 | MG | |||||||
| 127201811 | 12720181 | 9 | SS | CHLORDIAZEPOXIDE. | CHLORDIAZEPOXIDE | 1 | Unknown | 50 MG AT MORNING + 75 MG AT BEDTIME | Y | U | UNK | 0 | 125 | MG | |||||
| 127201811 | 12720181 | 10 | SS | CHLORDIAZEPOXIDE. | CHLORDIAZEPOXIDE | 1 | Unknown | 25 MG, EVERY 6 HOURS AS NEEDED | Y | U | UNK | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127201811 | 12720181 | 1 | Psychotherapy |
| 127201811 | 12720181 | 3 | Psychotherapy |
| 127201811 | 12720181 | 5 | Psychotherapy |
| 127201811 | 12720181 | 6 | Psychotherapy |
| 127201811 | 12720181 | 7 | Psychotherapy |
| 127201811 | 12720181 | 9 | Psychotherapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127201811 | 12720181 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127201811 | 12720181 | Cognitive disorder | |
| 127201811 | 12720181 | Delusion of replacement | |
| 127201811 | 12720181 | Dementia | |
| 127201811 | 12720181 | Multiple drug therapy | |
| 127201811 | 12720181 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |